Stocks to Watch: FB, LLY, T & More

Take a look at some of Wednesday's morning movers:


Facebook - The social network reported third quarter profit of $0.12 per share, beating estimates by a penny, with revenues also registering a small beat. In its conference call, the company encouraged investors by detailing progress in monetizing its mobile business. Several brokerage firms, including Bank of America/Merrill Lynch and Citi, have now upgraded the stock to "buy."

Eli Lilly - The drugmaker reported third quarter profit of $0.79 per share, four cents shy of estimates, while revenue came up short as well. Lilly also gave a yearly forecast that falls largely below estimates, with patent expirations on its Zyprexa drug weighing on worldwide revenue.

AT&T - The Dow component earned $0.62 per share, excluding certain items, two cents above estimates. The company says it had strong across-the-board performance and is increasing its free cash flow forecast as a result.

Boeing - Boeing earned $1.35 per share for the second quarter, 22 cents above estimates. The jet maker also raised its full-year guidance.

Wells Fargo - Warren Buffett told CNBC's "Squawk Box" that he bought more Wells Fargo shares over the past week. (Read More: Buffett: 'No Question' Global Economy Is Slowing)

Bristol-Myers Squibb - The drugmaker earned $0.41 per share for the third quarter, one cent below estimates. A bigger than expected drop in sales of its anti-clotting drug Plavix was among the factors pressuring results.

Northrop Grumman - The defense contractor earned $1.82 per share for its third quarter, 13 cents above estimates, and also raised its earnings forecast for the year.

Wyndham Worldwide - The hotel operator earned $1.13 per share, excluding items, for its third quarter, three cents above estimates. It also raised its revenue outlook for the year, as its exchange and rentals group helped mitigate the effect of European economic headwinds.

Gilead Sciences - Gilead earned $1.00 per share for the third quarter, six cents above estimates, with revenues also beating consensus. The biopharmaceutical company saw a 14% increase in product sales, including its HIV drugs Atripla and Truvada.

Amgen - Amgen reported third quarter profit of $1.67 per share, beating estimates by 20 cents. The biotech giant also raised its full year profit forecast, with sales of its bone cancer drug Xgeva nearly doubling its sales.

Netflix - The shares are under pressure after the company issued subscriber growth forecasts that fell below some analyst estimates.

Tempur-Pedic - Tempur-Pedic earned $0.70 per share for the third quarter, one cent above estimates. The mattress maker reported revenues below consensus, and also slashed its 2012 outlook on tough North American competition and economic weakness in Europe.

Broadcom - Broadcom reported third quarter profit of $0.79 per share, two cents above estimates. However, the chipmaker's revenue projections for the current quarter are below analyst forecasts.

Juniper Networks - The company earned $0.22 per share, excluding certain items, five cents below estimates. But the networking equipment maker issued current quarter guidance below analyst estimates, amid weak spending from its telecom customers.

Panera Bread - The restaurant operator earned $1.24 per share for the third quarter, beating estimates by five cents. Its revenue also was ahead of analyst forecasts, and it also increased its full year forecast on improving same store sales numbers.

Buffalo Wild Wings - The company lowered its earnings forecast for the year, with high prices for chicken wings negating the positive effects of upbeat sales.

Dow Chemical - Dow is cutting 5 percent of its workforce, about 2,400 jobs, and closing 20 manufacturing facilities. Dow expects to save $500 million per year by the end of 2014, with the restructuring resulting in a charge of $0.50 - $0.60 per share for the fourth quarter.

Zynga - Zynga is also cutting 5 percent of its workforce, as it announces plans to shut down its Boston studio and close offices in Japan and the U.K. The maker of social networking games also plans to spend significantly less on data hosting, advertising, and outside services.

Monster Beverage - Monster has issued a second statement standing by the safety of its products, as it continues to respond to a lawsuit alleging that its products were responsible for the death of 14-year old Anais Fournier. It's also responding to reports that the FDA is probing other deaths related to its drinks.

SAP - SAP reported third quarter profit that fell below estimates, but the maker of business software raised its full year sales forecast thanks to increasing business in the cloud computing segment.

—By CNBC's Peter Schacknow

Questions? Comments? Email us at